Skip to content

Homebased Monitoring Cardiac Rehabilitation Program

Effectiveness of a Homebased Cardiac Rehabilitation Program of Mixed Surveillance Using NUUBO Monitoring Vest in Patients With Ischemic Heart Disease at Moderate Cardiovascular Risk

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02796404
Acronym
NUUBO
Enrollment
148
Registered
2016-06-10
Start date
2015-08-31
Completion date
2017-06-30
Last updated
2016-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Homebased Cardiac Rehabilitation Program After Ischemic Heart Disease

Keywords

home monitoring, cardiac monitoring

Brief summary

The current state of mobile communication and technology is a tool to support home programs for chronic disease management, useful to facilitate access to these types of programs, because the investigators could obtain telematics information about the parameters, reducing cardiovascular risk factors and cardiovascular morbidity and mortality.

Detailed description

The current state of mobile communication and technology is a tool to support home programs for chronic disease management, useful to facilitate access to these types of programs, because the investigators could obtain telematics information about the parameters, reducing cardiovascular risk factors and cardiovascular morbidity and mortality. Once the patient qualifies for inclusion in the study and has signed informed consent it is included in a list where randomized 7 patients in the experimental group (home-based cardiac rehabilitation Nuubo monitoring vest) and 7 patients are assigned to traditional cardiac rehabilitation group.

Interventions

OTHERTraditional cardiac rehabilitation program

multidisciplinary intervention in cardiac rehabilitation gym

DEVICEHomebased cardiac rehabilitation program

homebased cardiac rehabilitation program with monitoring vest Nuubo

Sponsors

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

All of them: * Age ≤ 80 years. * Stable Ischemic heart disease, revascularized by angioplasty or underwent surgery by coronary bypass \<= one year from the acute episode. * Good cognitive level. * Ability to perform aerobic exercise tape or cycle ergometer. * Understand the use of a mobile Smartphone or Tablet. * Signature of informed consent. And at least one of the following: * Ventricular dysfunction by Ejection Fraction (FE) 40 - 50%. * Functional capacity 5-7 metabolic equivalents (METS). * Raising the blood pressure with the effort.

Exclusion criteria

* Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of Acute myocardial infarction (AMI) (\> 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and hemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled. * Previous infarcts. * Hypotensive response to exercise. * Myocardial Ischemia valued at exercise test. * Unstable Angina. * Nonrevascularizable disease. * Poorly controlled hypertension baseline. * Killip III and IV Killip. * No collaborator. * Valvular heart disease associated. * Pacemaker or Implantable Cardioverter Defibrillator. * Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation.

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness measured by exercise testing and control of cardiovascular risk factorsDuring 12 monthsfunctional capacity obtained by exercise testing and control of cardiovascular risk factors.

Secondary

MeasureTime frameDescription
Results of homebased cardiac rehabilitation monitoring a traditional cardiac rehabilitation programDuring 12 monthscomparing the results of functional capacity measured by exercise testing and control of cardiovascular risk factors between the two groups
Adherence to these programs3, 6 and 12 monthssee adherence to these program at 3, 6 months and a year depending on the habit of exercise and control of cardiovascular risk factors.
Safety to these programDuring 12 monthsSee the safety of home cardiac rehabilitation program of mixed surveillance compared to traditional cardiac rehabilitation program to checking the existence of adverse cardiac events.

Countries

Spain

Contacts

Primary ContactRaquel Bravo, MD
rbravoescobar@yahoo.es34951291977

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026